« Back to Record
Citation APA

Awada, A., de Valeriola, D., Gil, T., Kerger, J., Selleslags, J., Van Vreckem, A., Brassine, C., Hennebert, P., Riva, A., Piccart-Gebhart, M., et al. (1998). Influence of the cytoprotective agent Amifostine on toxicity and pharmacokinetics (PK) of Docetaxel (D) in metastasic breast cancer (MBC): A feasibility study of the EORTC-Investigational Drug Branch for Breast Cancer. Proceedings of the 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Vol. 55 (Juin 1998: Amsterdam, The Nederlands).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278626

Awada, A., de Valeriola, D., Gil, T., Kerger, J., Selleslags, J., Van Vreckem, A., Brassine, C., Hennebert, P., Riva, A., Piccart-Gebhart, M., et al. (1998). Influence of the cytoprotective agent Amifostine on toxicity and pharmacokinetics (PK) of Docetaxel (D) in metastasic breast cancer (MBC): A feasibility study of the EORTC-Investigational Drug Branch for Breast Cancer. Proceedings of the 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Vol. 55 (Juin 1998: Amsterdam, The Nederlands).